Giagtzidis Ioakeim, Papoutsis Ioakeim, Dimkas Theodoros, Diamantidis Christos, Avgeris Georgios, Karkos Christos, Papazoglou Konstantinos
5th Surgical Department, Hippokrateio General Hospital, Aristotle University of Thessaloniki, Thessaloniki, GRC.
Cureus. 2024 Sep 7;16(9):e68882. doi: 10.7759/cureus.68882. eCollection 2024 Sep.
Background Endovascular aneurysm repair (EVAR) has evolved into treatment of choice for infrarenal abdominal aortic aneurysms (AAA). Type II endoleaks, although frequently benign, can lead to sac enlargement and rupture. Management of these endoleaks by endovascular means can be quite challenging and may require complex techniques and assistance of interventional radiologists, not always available in all vascular units. This is a single-center study of management of type II endoleaks with transarterial coil embolization performed by vascular surgeons and with minimum requirements regarding the necessary equipment. Methods From 2017 to 2022, 13 patients with type II endoleak were treated. Local anaesthesia and transfemoral or transbrachial approach was used. The superficial mesenteric artery (SMA) was catheterized and through the Riolan arch, coiling of the inferior mesenteric artery and/or the sac aneurysm was performed. Results The mean time period between the primary EVAR procedure and the transarterial intervention for the endoleak was 3.9 years. Primary technical success was achieved in 11 (84.6%) patients, while secondary technical success was 12 (92.3%). In the mean follow-up period, which was 2.6 years, the endoleak was treated successfully in 11 (84.6%) patients. Conclusions Transarterial coil embolization of type II endoleaks is a minimal low-cost procedure, with small percentage of complications, high technical and treatment success rates. It could be considered as a first-line treatment of unresolvable type II endoleaks, minimizing the need for open repair.
血管内动脉瘤修复术(EVAR)已发展成为治疗肾下腹主动脉瘤(AAA)的首选方法。II型内漏虽然通常是良性的,但可导致瘤腔扩大和破裂。通过血管内方法处理这些内漏颇具挑战性,可能需要复杂技术以及介入放射科医生的协助,而并非所有血管单元都具备这些条件。这是一项单中心研究,探讨由血管外科医生采用经动脉线圈栓塞术处理II型内漏,且对所需设备要求最低。方法:2017年至2022年,对13例II型内漏患者进行治疗。采用局部麻醉及经股动脉或经肱动脉入路。将导管插入肠系膜上动脉(SMA),通过Riolan弓对肠系膜下动脉和/或瘤腔动脉瘤进行线圈栓塞。结果:初次EVAR手术与针对内漏的经动脉干预之间的平均时间为3.9年。11例(84.6%)患者取得了初次技术成功,12例(92.3%)取得了二次技术成功。在平均2.6年的随访期内,11例(84.6%)患者的内漏得到成功治疗。结论:II型内漏的经动脉线圈栓塞术是一种微创、低成本的手术,并发症发生率低,技术成功率和治疗成功率高。可将其视为无法解决的II型内漏的一线治疗方法,尽量减少开放修复的需求。